Induction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer

NCT01326923 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Principle Investigator left the institution.

Conditions

Head and Neck Squamous Cell Cancer

Interventions

DRUG: Cetuximab

Sponsor

Louisiana State University Health Sciences Center Shreveport